National Center for Tumor Diseases (NCT) Heidelberg
Tania Christiansen is currently a Resident in Medical Oncology at the National Center for Tumor Diseases (NCT) Heidelberg since June 2023. In addition to this role, Tania has been involved in a Medical Thesis Project at EMBL since October 2018, focusing on method development and single-cell data analysis using R and Rshiny. Previous positions include Scientist at the DKFZ German Cancer Research Center and Vaccinator of SARS-CoV-2 vaccines at the Vaccination Center Rhein-Neckar-Kreis. Earlier experience includes serving as a Student Research Assistant at the Institute for Anatomy and Cell Biology in Heidelberg, a Student Teaching Assistant in Anatomical Dissection, and a Bachelor Thesis Project at NCT Heidelberg. Tania holds a Staatsexamen in Medicine from Heidelberg University and a Bachelor of Science in Molecular Biotechnology, with numerous scholarships awarded for academic excellence.
National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. Since 2015, a second site for the NCT beside Heidelberg has been under development in Dresden.